ShimadaH,EndoI,ShimadaK,MatsuyamaR,KobayashiN,KubotaK., 2012.The current diagnosis and treatment of benign biliary stricture,Surg Today 42 1143 -53
MacFadyenBV,VecchioR,RicardoAE,MathisCR, 1998.Bile duct injury after laparoscopic cholecystectomy,The United States experience. Surg Endosc 12 315 -21
PascherA,NeuhausP, 2005.Bile duct complications after liver transplantation,Transpl Int 18 627 -42
WindsorJA,PongJ, 1998.Laparoscopic biliary injury: More than a learning curve problem,Aust N Z J Surg 68 186 -9
GengZM,ZhengJB,ZhangXX,TaoJ,WangL, 2008.Role of transforming growth factor-beta signaling pathway in pathogenesis of benign biliary stricture,World J Gastroenterol 14 4949 -54
GengZM,YaoYM,LiuQG,NiuXJ,LiuXG, 2005.Mechanism of benign biliary stricture: A morphological and immunohistochemical study,World J Gastroenterol 11 293 -5
XuJ,GengZM,MaQY, 2003.Microstructural and ultrastructural changes in the healing process of bile duct trauma,Hepatobiliary Pancreat Dis Int 2 295 -9
LiKY,ShiCX,HuangJZ,TangKL, 2016.Tetramethylpyrazine effects on the expression of scar-related genes in rabbit benign biliary stricture fibroblasts,J Coll Physicians Surg Pak 26 813 -7
HuangC,OgawaR., 2013.Pharmacological treatment for keloids,Expert Opin Pharmacother 14 2087 -100
SyedF,BayatA, 2013.Superior effect of combination vs. single steroid therapy in keloid disease: A comparative in vitro analysis of glucocorticoids,Wound Repair Regen 21 8 -102
WrzeszczA,DittrichB,HaamannD,AliuosP,KleeD,NolteI, 2014.Dexamethasone released from cochlear implant coatings combined with a protein repellent hydrogel layer inhibits fibroblast proliferation,J Biomed Mater Res A 102 442 -54
TianY,YangG,ZhangX,ShenW,DongJ,XuZ., 2014.Effects of substance P on growth of fibroblast-like cells derived from bile duct: An in vitro cell culture study,Chin Med J (Engl) 127 3121 -6
KuverR,SavardC,NguyenTD,OsborneWR,LeeSP, 1997.Isolation and long-term culture of gallbladder epithelial cells from wild-type and CF mice,In Vitro Cell Dev Biol Anim 33 104 -9
Gunter-SmithPJ,AbdulkadirO,Hammonds-OdieL,ScanlonM,Terrell R, 2000.A primary culture of guinea pig gallbladder epithelial cells that is responsive to secretagogues,Am J Physiol Gastrointest Liver Physiol 279 G866 -74
GauglitzGG,KortingHC,PavicicT,RuzickaT,JeschkeMG, 2011.Hypertrophic scarring and keloids: Pathomechanisms and current and emerging treatment strategies,Mol Med 17 113 -25
RabelloFB,SouzaCD,FarinaJJA, 2014.Update on hypertrophic scar treatment,Clinics (Sao Paulo) 69 565 -73
LiB,WangJH, 2011.Fibroblasts and myofibroblasts in wound healing: Force generation and measurement,J Tissue Viability 20 108 -20
BlobeGC,SchiemannWP,LodishHF, 2000.Role of transforming growth factor beta in human disease,N Engl J Med 342 1350 -8
TaipaleJ,SaharinenJ,Keski-OjaJ, 1998.Extracellular matrixassociated transforming growth factor-beta: Role in cancer cell growth and invasion,Adv Cancer Res 75 87 -134
MassagueJ., 2012.TGFbeta signalling in context,Nat Rev Mol Cell Biol 13 616 -30
MaciasMJ,Martin-MalpartidaP,MassagueJ, 2015.Structural determinants of Smad function in TGF-beta signaling,Trends Biochem Sci 40 296 -308
HanyuA,IshidouY,EbisawaT,ShimanukiT,ImamuraT,MiyazonoK., 2001.The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling,J Cell Biol 155 1017 -27
DerynckR,ZhangYE, 2003.Smad-dependent and Smad-independent pathways in TGF-beta family signalling,Nature 425 577 -84
SchwartzeJT,BeckerS,SakkasE,WujakLA,NiessG,UsemannJ, 2014.Glucocorticoids recruit Tgfbr3 and Smad1 to shift transforming growth factor-beta signaling from the Tgfbr1/Smad2/3 axis to the Acvrl1/Smad1 axis in lung fibroblasts,J Biol Chem 289 3262 -75